Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial

✍ Scribed by Wendy Keitel; Nicola Groth; Maria Lattanzi; Michaela Praus; Anne Katrin Hilbert; Astrid Borkowski; Ted F. Tsai

• Book ID: 116962119
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 950 KB
• Volume: 28
• Category: Article
• ISSN: 0264-410X
• DOI: 10.1016/j.vaccine.2009.10.019